Flavocure Biotech, LLC recently accomplished a major milestone — receiving Orphan Drug designation from the US Food and Drug Administration for their drug to treat acute myeloid leukemia.
Flavocure’s Founder and Executive Chairman, Dr. Henry Lowe, is a notable Jamaican scientist. Flavocure’s achievement is great news for Maryland and for Jamaica.
News of the US FDA approval was announced by the Prime Minister of Jamaica in a ceremony there last week. Several national news outlets covered the story, including The Gleaner and Jamaica Information Services.
![](http://jis.gov.jm/media/henryXLowe-640x425.jpg)
Jamaica’s Primer Minister, Most Honorable Andrew Holness (right) congratulating Flavocure Founder and Executive Chairman Dr. Henry Lowe (left). Photo Credit: JIS Photographer
![](http://imet.umces.edu/harborlaunch/wp-content/uploads/FLC-e1500321705320-300x227.jpg)
CEO of Flavocure, Ngeh Toyang, with the MD Department of Commerce at the BIO Int’l Convention in June. Photo Credit: MD Department of Commerce / Twitter
Congratulations , Dr. Henry Lowe
You have been a great credit to Jamaica in the field of science.
Congratulations are in order from the Kingsway High School Alumni Associations NY Chapter.